Tumor VEGF expression and serum VEGF levels are independent prognostic factors in curatively resected gastric cancer patients

M Pera, O Vidal, J Elizalde, A Soriano… - Journal of Clinical …, 2006 - ascopubs.org
4021 Background: Increased serum and/or tumor vascular endothelial growth factor (VEGF)
and urokinase-type plasminogen activator (uPA) have been shown to predict poor survival …

High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer

O Vidal, JP Metges, I Elizalde, M Valentíni… - Journal of British …, 2009 - academic.oup.com
Background Tumour vascular endothelial growth factor (VEGF) and tumour urokinase-type
plasminogen activator (uPA) are prognostic factors in gastric cancer but surgical specimens …

Serum VEGF and VEGF-C values before surgery and after postoperative treatment in gastric cancer

P Villarejo-Campos, D Padilla-Valverde… - Clinical and …, 2013 - Springer
Introduction Angiogenesis and lymphangiogenesis are essential processes for the formation
of blood and lymphatic vessels that allow tumour growth and spread. The binding of VEGF …

Prognostic value of angiogenesis in patients following curative resection of gastric cancer (GC)

O Vidal, JP Metges, A Soriano-Izquierdo… - Journal of Clinical …, 2005 - ascopubs.org
9605 Background: Despite novel therapies in GC, long-term prognosis remains poor.
Assessment of angiogenesis holds the promise of predicting outcome in an individual basis …

Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic …

Ó Vidal, A Soriano-Izquierdo, M Pera, JI Elizalde… - Journal of …, 2008 - Elsevier
Abstract Angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF) contribute to
gastric cancer aggressiveness by up-regulating the expression of proteases. We evaluated …

[HTML][HTML] Increased VEGF-C serum levels are predictive of a poor outcome in patients with resectable gastric cancer

MM Laterza, M Orditura, A Fabozzi, J Ventriglia… - Annals of …, 2014 - Elsevier
Aim: Vascular endothelial growth factor C (VEGF-C), also known as vascular endothelial
growth factor-related protein (VRP) is a VEGF growth factor family member playing a key …

Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in …

E Lieto, F Ferraraccio, M Orditura, P Castellano… - Annals of surgical …, 2008 - Springer
Background Unlike other human tumors, gastric cancer remains a great therapeutic
challenge since no standardized postoperative treatment exists. Knowledge of molecular …

The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma

FH Han, HM Li, DH Zheng, YL He, WH Zhan - European Journal of Surgical …, 2010 - Elsevier
AIMS: We aimed to investigate the relationship among VEGF-C/VEGFR-3 expression,
lymphatic metastasis and patient prognosis in gastric carcinoma. MATERIAL AND …

VEGF-C expression is associated with the poor survival in gastric cancer tissue

W Cao, R Fan, W Yang, Y Wu - Tumor Biology, 2014 - Springer
Vascular endothelial growth factor-C (VEGF-C) is considered as a prime mediator of
lymphangiogenesis and has been implicated in carcinogenesis and metastasis. Various …

Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer

Y Liu, S Guo, R Zhao, Y Chen, X Wang, K Xu - World journal of surgery, 2012 - Springer
Background Vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-
9 play important roles in tumor angiogenesis, development, and progression. This study …